Literature DB >> 1249997

An aflatoxin in the liver of a patient with Reye-Johnson syndrome.

E Chaves-Carballo, R D Ellefson, M R Gomez.   

Abstract

Liver specimens from 8 patients with Reye-Johnson syndrome, 2 patients with acute encephalopathy, and 10 patients without liver disease were analyzed for aflatoxins. An aflatoxin was obtained from the liver of one patient, a 15-year-old girl who had clinical, laboratory, and pathologic features of Reye-Johnson syndrome. Thin-layer chromatography, fluorescence emission, infrared spectroscopy, and derivatization studies characterized the aflatoxin as related structurally to but not identical with aflatoxin B1. This report is added to previous ones from Thailand, New Zealand, and Czechoslovakia in which the association of aflatoxins and fatty liver has been found in Reye-Johnson syndrome.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249997

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

Review 1.  Biological activities of mycotoxins.

Authors:  A W Hayes
Journal:  Mycopathologia       Date:  1978-12-18       Impact factor: 2.574

2.  Evidence of aflatoxin B1 in two cases of lung cancer in man.

Authors:  I Dvorackova; C Stora; N Ayraud
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

3.  The effect of aflatoxin B1 exposure on serotonin metabolism: response to a tryptophan load.

Authors:  T D Kimbrough; G C Llewellyn; L B Weekley
Journal:  Metab Brain Dis       Date:  1992-12       Impact factor: 3.584

4.  [Morphological characteristics and physiological properties of aflatoxin B1 producing and non-producing Aspergillus flavus strains].

Authors:  W Kogbo; S Lemarinier; P Boutibonnes
Journal:  Mycopathologia       Date:  1985-09       Impact factor: 2.574

5.  Does aflatoxin exposure in the United Kingdom constitute a cancer risk?

Authors:  J C Harrison; M Carvajal; R C Garner
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.